Abstract
Serum ferritin has been estimated in 125 untreated patients with Hodgkin's disease. Increasing concentrations are found at each advancing stage of the disease and high concentrations are found in patients with systemic symptoms. In all cases this is associated with a low serum Fe concentration and reduced transferrin saturation. There is no relationship between serum ferritin concentration and histological type of disease. The findings are compatible with a non-specific response of the reticuloendothelial system to malignancy, producing a secondary disorder of Fe metabolism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Jacobs, A., Slater, A., Whittaker, J. et al. Serum ferritin concentration in untreated Hodgkin's disease. Br J Cancer 34, 162–166 (1976). https://doi.org/10.1038/bjc.1976.138
Issue Date:
DOI: https://doi.org/10.1038/bjc.1976.138
This article is cited by
-
An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis
Biological Trace Element Research (1994)
-
Minor and trace elemental contents of cancerous breast tissue measured by instrumental and radiochemical neutron activation analysis
Biological Trace Element Research (1990)
-
Serum ferritin and malignant tumours
Medical Oncology and Tumor Pharmacotherapy (1984)